340Banter Podcast

In this episode of 340Banter, we break down one of the biggest operational challenges facing health centers today: documenting clinic-administered drugs. For many organizations, paper logs and spreadsheets are no longer enough to keep up with evolving manufacturer requirements. As the industry moves toward rebate models and medical claims data submissions, gaps in documentation and billing could p...

How often do HRSA Operational Site Visits (OSVs) occur, and what exactly are reviewers looking for during these important compliance assessments? In this episode of 340Banter, Chelsea Violette and Logan Yoho discuss recent updates to HRSA's Operational Site Visit (OSV) Protocol and how the changes help clarify expectations for health centers navigating compliance requirements. A key focus of the c...

What do all those 340B financial reports actually mean, and how can organizations make sense of them when every vendor seems to report data differently? In this episode of 340Banter, Chelsea Violette and Logan Yoho sit down with Michael Gonzalez, Founder of FQHC 340B Compliance, to unpack one of the biggest operational challenges facing 340B Programs today: navigating non-standardized financial re...

What exactly is an Annual Single Audit, and why does it matter for organizations participating in the 340B Drug Pricing Program? In this episode of 340Banter, Chelsea Violette and Logan Yoho sit down with Michael Gonzalez, Founder of FQHC 340B Compliance, to break down the essentials of the Single Audit process and its critical connection to pharmacy operations within 340B Programs. Whether you're...

Donavan received his Bachelor’s degree in pharmacy from the University of Utah College of Pharmacy in 1995. His past work experience includes being a retail pharmacist at Albertsons, a Director of Pharmacy at Gunnison Valley Hospital, and a Director of Pharmacy at Central Valley Medical Center. While at Gunnison Valley Hospital, he sat on the Pharmacy and Therapeutics committee and was an active m...

On this episode of 340Banter, Donovan Smith, CEO of Wayne Community Health Centers, details the real-world impact of the IRA’s Maximum Fair Price (MFP) implementation. He explains how claims are being misattributed to 340B, the challenges of a dual inventory model in a remote pharmacy, the financial strain from denied rebates and low dispensing fees, and the risks to patient access. Donovan also d...

In this episode, we explore a powerful and timely topic: How to reteach yourself how to learn. Whether you’re returning to school, starting a new career, rebuilding confidence, or simply feeling stuck, learning as an adult can feel very different than it did before. The good news? Learning is a skill, and it can be rebuilt. This conversation dives into the mindset shifts, habits, and strategies th...

In this episode of the 340Banter Podcast, co-hosts Chelsea Violette and Logan Yoho take a closer look at MFP Drugs, the first prescription medications selected for Maximum Fair Price (MFP) under Medicare’s new drug pricing authority. With Medicare now negotiating prices for some of the most widely used and expensive drugs in the U.S., the spotlight is on how these MFP drug selections will affect p...

In this episode of the 340Banter Podcast, co-hosts Chelsea Violette and Logan Yoho break down the latest on Maximum Fair Price (MFP) under the Inflation Reduction Act and ask the big question: How’s it going so far? As Medicare drug price negotiations move from policy theory to real-world implementation, stakeholders across the healthcare system are feeling the impact. Chelsea and Logan unpack wha...

Running a clinical pharmacy under 340B isn’t just about discounts; it’s about delivering high-quality care and maximizing the program's value. Jamie Kim shares strategies for using 340B savings to expand clinical pharmacy services, improve patient access, and enhance outcomes while remaining compliant. This episode is especially helpful for administrators and pharmacy directors looking to get the...

Accurate UDS reporting is crucial for health centers, but many overlook the role of pharmacy operations and 340B activity in this process. Matthew Krah walks listeners through key considerations for integrating pharmacy and 340B data into Uniform Data System (UDS) reporting. Learn how to ensure your 340B-related prescriptions and savings are properly documented, and avoid common reporting mistakes...

Specialty pharmacies are playing a growing role under 340B, but with that growth comes complexity. Jamie Kim explains how 340B impacts specialty drug distribution, what 340B-eligible health centers need to know before partnering, and where the biggest compliance and financial risks lie. Whether you’re managing a contract pharmacy or overseeing 340B strategy in your organization, this episode offer...

Join us as Matt Krah walks through best practices for maintaining a 340B Third-Party Administrator (TPA) program. We cover how TPAs help ensure compliance, manage claims, and streamline contract-pharmacy networks, as well as key red flags to watch out for. If you run or support a 340B covered entity, this episode gives you practical insights to avoid pitfalls and stay audit-ready.

How is provider reporting evolving in today’s 340B environment? Recorded live from the conference floor, this episode of 340Banter brings together co-host Logan Yoho and guest co-host Felicity Homsted to unpack the shifting landscape that covered entities are facing. From new reporting requirements to the impact of technology and data management, this discussion explores the key changes leaders ne...

How can milestone moments spark meaningful advocacy and community engagement in the 340B space? Recorded live from the conference floor, this episode of 340Banter features Brenda Reitz, Pharmacy Director at Family Health Services, with co-host Logan Yoho and guest host Felicity Homsted. Brenda shares how her organization’s 20th anniversary celebration became more than a milestone—it became a catal...

What surprises are covered entities facing in HRSA-approved manufacturer audits today? Recorded live from the conference floor, this episode of 340Banter features Madeline Wallack, Founder of Rx|X Consulting & Avanti340B, alongside co-host Logan Yoho and guest host Felicity Homsted. Together, they share real-world insights from the frontlines of manufacturer audits and discuss how FQHCs and ot...

What does the new 340B Rebate Model Pilot mean for FQHCs and covered entities navigating today’s 340B landscape? In this episode of 340Banter, co-host Logan Yoho and guest host Felicity Homsted break down the details of this evolving initiative and what it could mean for compliance, program savings, and manufacturer relationships. From understanding the intent of the pilot to anticipating potentia...

How can you stay compliant while managing the growing complexity of 340B programs? In Episode 15 of 340Banter, Charnay Ingram and LaNika Ellis share proven oversight strategies that keep their programs running smoothly and audit-ready. From tracking changes to engaging internal stakeholders, this episode offers practical, scalable tips that every 340B leader needs to hear—whether you're overseeing...

What’s driving the surge in state contract pharmacy protection laws—and how does a 340B-related bill actually become a law? In Episode 14 of 340Banter, co-hosts Chelsea Violette and Logan Yoho break it all down with clarity, insight, and real-world relevance. Whether you're advocating for change, tracking legislation, or trying to understand your state’s protections, this episode gives you the fou...

How do 340B professionals grow, pivot, and thrive in this complex program space? In Episode 13 of the 340Banter Podcast, Chris Christian and LaNika Ellis share their inspiring and unconventional career journeys within the 340B world—from clinic operations to program management and advocacy. Whether you're new to 340B or a seasoned professional looking to grow your role, this conversation is filled...

What really happens during a 340B HRSA audit? In Episode 12 of 340Banter, Richard Cox from Hope Family Health and Chris Christian from FQHC 340B Compliance walk us through their firsthand audit experience, sharing what worked, what they learned, and how they stayed prepared every step of the way. Whether you're facing an upcoming HRSA audit or just want to strengthen your 340B compliance practices...

In this episode of 340Banter, Rhiannon Klein shares grounded, real-world strategies for building an impactful advocacy presence. Drawing from her experience leading Community Voice of 340B, she discusses how to mobilize communities, craft compelling messages, and stay resilient in the face of challenges. Tune in for clear, actionable guidance on becoming a more confident and effective advocate in...

In this episode of 340Banter, Derek Pihl, PharmD, shares key takeaways from his advocacy work at both the state and federal levels. From building legislative relationships to navigating challenges in public health policy, Derek offers lessons learned and strategies for effective 340B engagement. Tune in for practical insights, inspiring stories, and actionable advice to help you make a meaningful...

In this practical and perspective-rich episode, co-hosts Chelsea Violette and Logan Yoho sit down with Michael Gonzalez of FQHC 340B Compliance to talk all things vendors—how to evaluate them, collaborate effectively, and avoid common pitfalls. Michael shares his expert take on what makes a strong vendor relationship, the red flags to watch for, and how FQHCs can ensure vendors are aligned with co...

In this eye-opening episode, co-hosts Chelsea Violette and Logan Yoho sit down with Felicity Homsted, CEO of FQHC 340B Compliance, to unpack one of the most pressing issues facing the 340B community today—manufacturer restrictions. Felicity brings a data-driven, policy-informed perspective to the conversation, shedding light on how these restrictions impact patient care, covered entities, and the...